Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: Study protocol of a non-inferiority, randomized controlled trial

Tina M. Slusher, Bolajoko O. Olusanya, Hendrik J. Vreman, Ronald J. Wong, Ann M. Brearley, Yvonne E. Vaucher, David K. Stevenson

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Severe neonatal jaundice and its progression to kernicterus is a leading cause of death and disability among newborns in poorly-resourced countries, particularly in sub-Saharan Africa. The standard treatment for jaundice using conventional phototherapy (CPT) with electric artificial blue light sources is often hampered by the lack of (functional) CPT devices due either to financial constraints or erratic electrical power. In an attempt to make phototherapy (PT) more readily available for the treatment of pathologic jaundice in underserved tropical regions, we set out to test the hypothesis that filtered sunlight phototherapy (FS-PT), in which potentially harmful ultraviolet and infrared rays are appropriately screened, will be as efficacious as CPT.Methods/design: This prospective, non-blinded randomized controlled non-inferiority trial seeks to enroll infants with elevated total serum/plasma bilirubin (TSB, defined as 3 mg/dl below the level recommended by the American Academy of Pediatrics for high-risk infants requiring PT) who will be randomly and equally assigned to receive FS-PT or CPT for a total of 616 days at an inner-city maternity hospital in Lagos, Nigeria. Two FS-PT canopies with pre-tested films will be used. One canopy with a film that transmits roughly 33% blue light (wavelength range: 400 to 520 nm) will be used during sunny periods of a day. Another canopy with a film that transmits about 79% blue light will be used during overcast periods of the day. The infants will be moved from one canopy to the other as needed during the day with the goal of keeping the blue light irradiance level above 8 μW/cm2/nm.Primary outcome: FS-PT will be as efficacious as CPT in reducing the rate of rise in bilirubin levels. Secondary outcome: The number of infants requiring exchange transfusion under FS-PT will not be more than those under CPT.Conclusion: This novel study offers the prospect of an effective treatment for infants at risk of severe neonatal jaundice and avoidable exchange transfusion in poorly-resourced settings without access to (reliable) CPT in the tropics. Trial registration: ClinicalTrials.gov Identifier: NCT01434810.

Original languageEnglish (US)
Article number446
JournalTrials
Volume14
Issue number1
DOIs
StatePublished - Dec 28 2013

Fingerprint

Neonatal Jaundice
Phototherapy
Sunlight
Newborn Infant
Therapeutics
Light
Jaundice
Non-Randomized Controlled Trials
Bilirubin
Kernicterus
Infrared Rays
Maternity Hospitals
Africa South of the Sahara
Urban Hospitals
Ultraviolet Rays
Nigeria

Keywords

  • Africa
  • Developing country
  • Filtered sunlight phototherapy
  • Hyperbilirubinemia
  • Irradiance
  • Low-cost technologies

Cite this

Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates : Study protocol of a non-inferiority, randomized controlled trial. / Slusher, Tina M.; Olusanya, Bolajoko O.; Vreman, Hendrik J.; Wong, Ronald J.; Brearley, Ann M.; Vaucher, Yvonne E.; Stevenson, David K.

In: Trials, Vol. 14, No. 1, 446, 28.12.2013.

Research output: Contribution to journalArticle

Slusher, Tina M. ; Olusanya, Bolajoko O. ; Vreman, Hendrik J. ; Wong, Ronald J. ; Brearley, Ann M. ; Vaucher, Yvonne E. ; Stevenson, David K. / Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates : Study protocol of a non-inferiority, randomized controlled trial. In: Trials. 2013 ; Vol. 14, No. 1.
@article{8155fb3b1b7a4cd79fa56ceeb1bfc924,
title = "Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: Study protocol of a non-inferiority, randomized controlled trial",
abstract = "Background: Severe neonatal jaundice and its progression to kernicterus is a leading cause of death and disability among newborns in poorly-resourced countries, particularly in sub-Saharan Africa. The standard treatment for jaundice using conventional phototherapy (CPT) with electric artificial blue light sources is often hampered by the lack of (functional) CPT devices due either to financial constraints or erratic electrical power. In an attempt to make phototherapy (PT) more readily available for the treatment of pathologic jaundice in underserved tropical regions, we set out to test the hypothesis that filtered sunlight phototherapy (FS-PT), in which potentially harmful ultraviolet and infrared rays are appropriately screened, will be as efficacious as CPT.Methods/design: This prospective, non-blinded randomized controlled non-inferiority trial seeks to enroll infants with elevated total serum/plasma bilirubin (TSB, defined as 3 mg/dl below the level recommended by the American Academy of Pediatrics for high-risk infants requiring PT) who will be randomly and equally assigned to receive FS-PT or CPT for a total of 616 days at an inner-city maternity hospital in Lagos, Nigeria. Two FS-PT canopies with pre-tested films will be used. One canopy with a film that transmits roughly 33{\%} blue light (wavelength range: 400 to 520 nm) will be used during sunny periods of a day. Another canopy with a film that transmits about 79{\%} blue light will be used during overcast periods of the day. The infants will be moved from one canopy to the other as needed during the day with the goal of keeping the blue light irradiance level above 8 μW/cm2/nm.Primary outcome: FS-PT will be as efficacious as CPT in reducing the rate of rise in bilirubin levels. Secondary outcome: The number of infants requiring exchange transfusion under FS-PT will not be more than those under CPT.Conclusion: This novel study offers the prospect of an effective treatment for infants at risk of severe neonatal jaundice and avoidable exchange transfusion in poorly-resourced settings without access to (reliable) CPT in the tropics. Trial registration: ClinicalTrials.gov Identifier: NCT01434810.",
keywords = "Africa, Developing country, Filtered sunlight phototherapy, Hyperbilirubinemia, Irradiance, Low-cost technologies",
author = "Slusher, {Tina M.} and Olusanya, {Bolajoko O.} and Vreman, {Hendrik J.} and Wong, {Ronald J.} and Brearley, {Ann M.} and Vaucher, {Yvonne E.} and Stevenson, {David K.}",
year = "2013",
month = "12",
day = "28",
doi = "10.1186/1745-6215-14-446",
language = "English (US)",
volume = "14",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates

T2 - Study protocol of a non-inferiority, randomized controlled trial

AU - Slusher, Tina M.

AU - Olusanya, Bolajoko O.

AU - Vreman, Hendrik J.

AU - Wong, Ronald J.

AU - Brearley, Ann M.

AU - Vaucher, Yvonne E.

AU - Stevenson, David K.

PY - 2013/12/28

Y1 - 2013/12/28

N2 - Background: Severe neonatal jaundice and its progression to kernicterus is a leading cause of death and disability among newborns in poorly-resourced countries, particularly in sub-Saharan Africa. The standard treatment for jaundice using conventional phototherapy (CPT) with electric artificial blue light sources is often hampered by the lack of (functional) CPT devices due either to financial constraints or erratic electrical power. In an attempt to make phototherapy (PT) more readily available for the treatment of pathologic jaundice in underserved tropical regions, we set out to test the hypothesis that filtered sunlight phototherapy (FS-PT), in which potentially harmful ultraviolet and infrared rays are appropriately screened, will be as efficacious as CPT.Methods/design: This prospective, non-blinded randomized controlled non-inferiority trial seeks to enroll infants with elevated total serum/plasma bilirubin (TSB, defined as 3 mg/dl below the level recommended by the American Academy of Pediatrics for high-risk infants requiring PT) who will be randomly and equally assigned to receive FS-PT or CPT for a total of 616 days at an inner-city maternity hospital in Lagos, Nigeria. Two FS-PT canopies with pre-tested films will be used. One canopy with a film that transmits roughly 33% blue light (wavelength range: 400 to 520 nm) will be used during sunny periods of a day. Another canopy with a film that transmits about 79% blue light will be used during overcast periods of the day. The infants will be moved from one canopy to the other as needed during the day with the goal of keeping the blue light irradiance level above 8 μW/cm2/nm.Primary outcome: FS-PT will be as efficacious as CPT in reducing the rate of rise in bilirubin levels. Secondary outcome: The number of infants requiring exchange transfusion under FS-PT will not be more than those under CPT.Conclusion: This novel study offers the prospect of an effective treatment for infants at risk of severe neonatal jaundice and avoidable exchange transfusion in poorly-resourced settings without access to (reliable) CPT in the tropics. Trial registration: ClinicalTrials.gov Identifier: NCT01434810.

AB - Background: Severe neonatal jaundice and its progression to kernicterus is a leading cause of death and disability among newborns in poorly-resourced countries, particularly in sub-Saharan Africa. The standard treatment for jaundice using conventional phototherapy (CPT) with electric artificial blue light sources is often hampered by the lack of (functional) CPT devices due either to financial constraints or erratic electrical power. In an attempt to make phototherapy (PT) more readily available for the treatment of pathologic jaundice in underserved tropical regions, we set out to test the hypothesis that filtered sunlight phototherapy (FS-PT), in which potentially harmful ultraviolet and infrared rays are appropriately screened, will be as efficacious as CPT.Methods/design: This prospective, non-blinded randomized controlled non-inferiority trial seeks to enroll infants with elevated total serum/plasma bilirubin (TSB, defined as 3 mg/dl below the level recommended by the American Academy of Pediatrics for high-risk infants requiring PT) who will be randomly and equally assigned to receive FS-PT or CPT for a total of 616 days at an inner-city maternity hospital in Lagos, Nigeria. Two FS-PT canopies with pre-tested films will be used. One canopy with a film that transmits roughly 33% blue light (wavelength range: 400 to 520 nm) will be used during sunny periods of a day. Another canopy with a film that transmits about 79% blue light will be used during overcast periods of the day. The infants will be moved from one canopy to the other as needed during the day with the goal of keeping the blue light irradiance level above 8 μW/cm2/nm.Primary outcome: FS-PT will be as efficacious as CPT in reducing the rate of rise in bilirubin levels. Secondary outcome: The number of infants requiring exchange transfusion under FS-PT will not be more than those under CPT.Conclusion: This novel study offers the prospect of an effective treatment for infants at risk of severe neonatal jaundice and avoidable exchange transfusion in poorly-resourced settings without access to (reliable) CPT in the tropics. Trial registration: ClinicalTrials.gov Identifier: NCT01434810.

KW - Africa

KW - Developing country

KW - Filtered sunlight phototherapy

KW - Hyperbilirubinemia

KW - Irradiance

KW - Low-cost technologies

UR - http://www.scopus.com/inward/record.url?scp=84891042516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891042516&partnerID=8YFLogxK

U2 - 10.1186/1745-6215-14-446

DO - 10.1186/1745-6215-14-446

M3 - Article

C2 - 24373547

AN - SCOPUS:84891042516

VL - 14

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 446

ER -